Literature DB >> 21196102

Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia.

E Jarauta1, R Mateo-Gallego, R Gilabert, N Plana, M Junyent, E de Groot, A Cenarro, L Masana, E Ros, F Civeira.   

Abstract

BACKGROUND AND AIMS: Familial hypercholesterolaemia (FH) and familial combined hyperlipidaemia (FCH) are common atherogenic disorders with great variability in cardiovascular disease (CVD). No direct atherosclerosis burden comparisons have been performed between FH and FCH in relation to lipoprotein particle distribution. METHODS AND
RESULTS: Risk factors and three measures of carotid intima-media thickness (IMT) in both sides were determined in 572 FH, 250 FCH and 200 controls. Lipoproteins were assessed by nuclear magnetic resonance (NMR) spectroscopy. Compared with controls, IMT measures were increased in FH and FCH. FCH had the highest adjusted mean-maximum IMT. FH had twice low-density lipoprotein (LDL) particles than controls, but similar LDL subclass size and distribution. FCH subjects also had increased LDL particles and the highest number of small LDL (1519 ± 731 nmol l(-1) vs. 887 ± 784 nmol l(-1) in FH and 545 ± 409 nmol l(-1) in controls). Age, gender, cholesterol/high-density lipoprotein (HDL) ratio, smoking and systolic blood pressure were independently associated with IMT in FH (r(2) = 0.38). The same variables, except cholesterol/HDL ratio, were associated with IMT in FCH (r(2) = 0.40). Among NMR lipoproteins, only VLDL and chylomicrons increased IMT prediction in FCH by 0.8%.
CONCLUSION: FH and FCH subjects show increased carotid atherosclerosis in relation to classical risk factors. Lipoprotein subclasses do not substantially contribute to IMT variability.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21196102     DOI: 10.1016/j.numecd.2010.10.011

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  10 in total

1.  Predictive Factors for Coronary Artery Disease among Peritoneal Dialysis Patients without Diabetic Nephropathy.

Authors:  Andreea Andronesi; Luminita Iliuta; Magdalena Patruleasa; Camelia Achim; Gener Ismail; Raluca Bobeica; Elena Rusu; Diana Zilisteanu; Danut Andronesi; Otilia Motoi; Alecse Ditoiu; Ionel Copaci; Mihai Voiculescu
Journal:  Maedica (Buchar)       Date:  2012-09

2.  Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.

Authors:  Arpita Basu; Alicia J Jenkins; Ying Zhang; Julie A Stoner; Richard L Klein; Maria F Lopes-Virella; W Timothy Garvey; Timothy J Lyons
Journal:  Atherosclerosis       Date:  2015-10-31       Impact factor: 5.162

3.  HDL size is more accurate than HDL cholesterol to predict carotid subclinical atherosclerosis in individuals classified as low cardiovascular risk.

Authors:  Eliane Soler Parra; Natalia Baratella Panzoldo; Vanessa Helena de Souza Zago; Daniel Zanetti Scherrer; Fernanda Alexandre; Jamal Bakkarat; Valeria Sutti Nunes; Edna Regina Nakandakare; Eder Carlos Rocha Quintão; Wilson Nadruz; Eliana Cotta de Faria; Andrei C Sposito
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

4.  Factors Significantly Associated With the Increased Prevalence of Carotid Atherosclerosis in a Northeast Chinese Middle-aged and Elderly Population: A Cross-sectional Study.

Authors:  Xi-Feng Pan; Ya-Xin Lai; Jian-Qiu Gu; Hao-Yu Wang; Ai-Hua Liu; Zhong-Yan Shan
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia.

Authors:  Elisenda Climent; Sofía Pérez-Calahorra; Victoria Marco-Benedí; Nuria Plana; Rosa Sánchez; Emilio Ros; Juan F Ascaso; Jose Puzo; Fátima Almagro; Carlos Lahoz; Fernando Civeira; Juan Pedro-Botet
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

6.  Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.

Authors:  Mahtab Sharifi; Elizabeth Higginson; Sven Bos; Angela Gallivan; Darren Harvey; Ka Wah Li; Amali Abeysekera; Angela Haddon; Helen Ashby; Kate E Shipman; Jackie A Cooper; Marta Futema; Jeanine E Roeters van Lennep; Eric J G Sijbrands; Mourad Labib; Devaki Nair; Steve E Humphries
Journal:  Atherosclerosis       Date:  2017-05-13       Impact factor: 5.162

7.  Familial Combined Hyperlipidemia (FCH) Patients with High Triglyceride Levels Present with Worse Lipoprotein Function Than FCH Patients with Isolated Hypercholesterolemia.

Authors:  Núria Puig; Inka Miñambres; Sonia Benítez; Pedro Gil; Margarida Grau-Agramunt; Andrea Rivas-Urbina; Antonio Pérez; José Luis Sánchez-Quesada
Journal:  Biomedicines       Date:  2020-01-06

8.  Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia.

Authors:  Giuseppe Mandraffino; Carmela Morace; Maria Stella Franzè; Veronica Nassisi; Davide Sinicropi; Maria Cinquegrani; Carlo Saitta; Riccardo Scoglio; Sebastiano Marino; Alessandra Belvedere; Valentina Cairo; Alberto Lo Gullo; Michele Scuruchi; Giovanni Raimondo; Giovanni Squadrito
Journal:  Biomedicines       Date:  2022-07-22

9.  A Ketogenic Low-Carbohydrate High-Fat Diet Increases LDL Cholesterol in Healthy, Young, Normal-Weight Women: A Randomized Controlled Feeding Trial.

Authors:  Jonas Burén; Madelene Ericsson; Nágila Raquel Teixeira Damasceno; Anna Sjödin
Journal:  Nutrients       Date:  2021-03-02       Impact factor: 5.717

10.  Long-term fasting improves lipoprotein-associated atherogenic risk in humans.

Authors:  Franziska Grundler; Dietmar Plonné; Robin Mesnage; Diethard Müller; Cesare R Sirtori; Massimiliano Ruscica; Françoise Wilhelmi de Toledo
Journal:  Eur J Nutr       Date:  2021-05-07       Impact factor: 5.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.